Premium
Preparation and evaluation of effect on Escherichia coli and Staphylococcus aureus of radiolabeled ampicillin‐loaded graphene oxide nanoflakes
Author(s) -
Yurt Fatma,
Ersöz Onur Alp,
Harputlu Ersan,
Ocakoglu Kasim
Publication year - 2018
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.13171
Subject(s) - ampicillin , escherichia coli , graphene , staphylococcus aureus , nuclear chemistry , fourier transform infrared spectroscopy , chemistry , oxide , in vivo , antibiotics , microbiology and biotechnology , bacteria , materials science , biochemistry , nanotechnology , biology , organic chemistry , chemical engineering , genetics , engineering , gene
Ampicillin is a one of effective antibiotics against Gram‐positive and Gram‐negative bacteria. This study aimed to label ampicillin‐loaded graphene oxide nanoflake ( AMP ‐ GO ) with 99m Tc and evaluate of its in vitro binding to Staphylococcus aureus and Escherichia coli . Firstly, ampicillin was loaded into graphene oxide nanoflake prepared. AMP ‐ GO was characterized by Fourier transform infrared spectroscopy ( FTIR ) and scanning electron microscope ( SEM ) techniques, and the amount of loaded ampicillin onto GO was determined by UV ‐Vis absorption spectroscopy. AMP and AMP ‐ GO were labeled with 99m Tc using stannous chloride reducing agent. Labeling efficiency of 99m Tc‐ AMP ‐ GO was found to be 97.66 ± 2.06%. 99m Tc‐ AMP ‐ GO has higher binding efficiencies to both S. aureus and E. coli than 99m Tc‐ AMP . 99m Tc‐ AMP ‐ GO could be promising candidate as agent infection nuclear imaging. Furthermore, in vivo studies of 99m Tc‐ AMP ‐ GO with infected rats are planned to be performed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom